Journal
IUBMB LIFE
Volume 60, Issue 8, Pages 483-496Publisher
WILEY
DOI: 10.1002/iub.56
Keywords
enzyme mechanisms; eukaryotic gene expression; molecular genetics; phosphoinositides; protein function; protein synthesis; signal transduction
Categories
Funding
- NIGMS NIH HHS [R01 GM079176-03, R01 GM079176] Funding Source: Medline
Ask authors/readers for more resources
The target of rapamycin (TOR) is a protein kinase with numerous functions in cell growth control. Some of these functions can be potently inhibited by rapamycin, an immunosuppressive and potential anticancer drug. TOR exists as part of two functionally distinct protein complexes. The functions of TOR complex 1 (TORC1) are effectively inhibited by rapamycin, but the mechanism for this inhibition remains elusive. The identification of TORC2 and recent reports that rapamycin can inhibit TORC2 functions, in some cases, challenge current models of TOR regulation. This review discusses the latest findings in yeast and mammals on the possible mechanisms that control TOR activity leading to its many cellular functions. (c) 2008 IUBMB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
